IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

RAMBALDI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 33.787
AS - Asia 22.169
NA - Nord America 21.908
SA - Sud America 2.820
OC - Oceania 577
AF - Africa 534
Continente sconosciuto - Info sul continente non disponibili 33
Totale 81.828
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.593
DE - Germania 11.840
CN - Cina 7.330
GB - Regno Unito 5.760
IT - Italia 5.733
SG - Singapore 4.488
JP - Giappone 2.063
BR - Brasile 1.830
RU - Federazione Russa 1.617
FR - Francia 1.590
ES - Italia 1.548
HK - Hong Kong 1.502
IN - India 1.456
SE - Svezia 1.181
BD - Bangladesh 1.122
VN - Vietnam 1.089
CA - Canada 864
IE - Irlanda 664
NL - Olanda 612
TR - Turchia 603
FI - Finlandia 571
KR - Corea 491
AU - Australia 489
CH - Svizzera 426
ID - Indonesia 397
PL - Polonia 342
MX - Messico 275
AR - Argentina 274
UA - Ucraina 273
AT - Austria 266
CO - Colombia 266
GR - Grecia 237
TW - Taiwan 223
TH - Thailandia 195
DK - Danimarca 190
PK - Pakistan 185
BE - Belgio 171
IL - Israele 158
SA - Arabia Saudita 144
PT - Portogallo 129
PH - Filippine 112
IR - Iran 111
CZ - Repubblica Ceca 108
EC - Ecuador 105
CL - Cile 103
IQ - Iraq 103
EU - Europa 99
EG - Egitto 98
PE - Perù 98
ZA - Sudafrica 96
RO - Romania 91
MY - Malesia 87
NZ - Nuova Zelanda 87
CI - Costa d'Avorio 83
UY - Uruguay 71
HU - Ungheria 64
MA - Marocco 60
HR - Croazia 57
JO - Giordania 56
NO - Norvegia 56
TN - Tunisia 49
UZ - Uzbekistan 40
RS - Serbia 34
LT - Lituania 33
VE - Venezuela 33
CR - Costa Rica 32
KE - Kenya 31
BG - Bulgaria 28
SK - Slovacchia (Repubblica Slovacca) 27
PY - Paraguay 25
AE - Emirati Arabi Uniti 24
SI - Slovenia 23
ET - Etiopia 20
LB - Libano 20
JM - Giamaica 19
KZ - Kazakistan 19
PR - Porto Rico 19
BY - Bielorussia 18
QA - Qatar 18
CY - Cipro 16
MK - Macedonia 16
NI - Nicaragua 16
KW - Kuwait 15
DZ - Algeria 14
EE - Estonia 14
NP - Nepal 14
BA - Bosnia-Erzegovina 13
BO - Bolivia 13
HN - Honduras 13
SC - Seychelles 13
AM - Armenia 12
DO - Repubblica Dominicana 12
NG - Nigeria 12
PA - Panama 12
RE - Reunion 12
TT - Trinidad e Tobago 11
AD - Andorra 10
AZ - Azerbaigian 10
GT - Guatemala 10
LU - Lussemburgo 10
Totale 81.712
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 9.767
Southend 4.273
Singapore 2.440
Ashburn 1.739
Milan 1.286
Hong Kong 1.216
Beijing 1.046
San Jose 957
Dallas 942
Fairfield 941
Seattle 873
Chandler 812
Wilmington 698
Dublin 649
Princeton 624
Houston 614
Council Bluffs 611
Tokyo 597
New York 510
Los Angeles 496
Redwood City 488
Woodbridge 487
Guangzhou 447
Rome 444
Shanghai 436
Cambridge 417
Helsinki 348
Nanjing 336
Madrid 326
Santa Clara 323
Moscow 314
Bengaluru 305
Ann Arbor 300
Lauterbourg 299
Hefei 291
Ho Chi Minh City 290
Buffalo 269
Hanoi 267
Jakarta 263
São Paulo 259
Barcelona 230
Des Moines 230
Chicago 222
Hangzhou 222
Tianjin 220
Toronto 216
London 213
Paris 181
Jacksonville 178
The Dalles 178
Columbus 170
Dearborn 160
Berlin 159
Istanbul 155
Shenyang 155
Florence 153
Bogotá 149
Hanover 143
Seoul 142
Boardman 140
Munich 138
Mumbai 134
Bologna 133
Jinan 132
Sydney 128
Hyderabad 127
Redmond 127
Vienna 125
Phoenix 116
Bangkok 112
Boston 109
Naples 109
Nuremberg 109
Taipei 109
Montreal 108
Cangzhou 107
Warsaw 106
Dong Ket 104
Shenzhen 104
Changsha 103
San Diego 103
Chengdu 102
Osaka 98
Athens 95
Buenos Aires 93
Amsterdam 92
Rochester 92
Zurich 92
Turin 90
Washington 90
Atlanta 87
Melbourne 86
Mountain View 86
Riyadh 84
Zhengzhou 84
Rio de Janeiro 83
Wuhan 82
Abidjan 81
Hamburg 81
Serra 79
Totale 45.736
Salva come PNG Salva come JPEG
Nome #
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia : Final Results of the Randomized Italian-German APL0406 Trial 5.985
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients : Final analysis of a prospective randomized trial 4.380
MIPSS70 : Mutation-enhanced international prognostic score system for transplantation-age patients with primary myelofibrosis 2.952
Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma 2.109
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab : Results From a Phase II, Single-Arm, Multicenter Study 1.710
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial 1.365
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19 1.312
Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia 926
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes 899
Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas 897
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial 747
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia 699
Second cancers in MPN : Survival analysis from an international study 684
Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group 634
Open-Label, phase 2 study of blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma 609
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms : an European Leukemia Net study 592
Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study 521
Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosis 483
Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma 453
Associations between gender, disease features and symptom burden in the MPN population : An analysis by the MPN QOL International Working Group 433
High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults 426
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 419
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia : a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus 391
SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma 389
A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma 373
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation 352
Achieving a Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long Term Outcome 344
At the peak of Covid-19 age and disease severity but not comorbidities are predictors of mortality. Covid-19 burden in Bergamo, Italy 339
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project 323
Identification of kitM541l somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response 317
Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue 317
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG) 317
Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic Microangiopathy 316
Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia 309
Endothelial injury and thrombotic microangiopathy in COVID-19 : Treatment with the lectin-pathway inhibitor narsoplimab 299
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 297
Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 289
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study 287
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients 283
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 279
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years : NILG ALL 10/07 279
Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia 276
Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera 273
Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3 267
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial 264
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera 261
A phase II study on intensive all type chemotherapy with minimal residual disease (MRD) oriented postremission strategy in adult patients with lymphoblastic lymphoma (PROTOCOL NILG-ALL NO.09/00) 261
The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning : a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo 260
Primary treatment response rather than front line stem cell transplantation is crucial for long term outcome of peripheral T-cell lymphomas 256
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia 255
Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel 252
Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia : a report from the MPN subcommittee of the chronic malignancies working party of the European group for blood and marrow transplantation 251
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells 251
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome : a study from the Gruppo Italiano Trapianto di Midollo Osseo(GITMO) 250
CEBPA-double-mutated acute myeloid leukemia displays a unique phenotypic profile : a reliable screening method and insight into biological features 248
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 247
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status 246
IDH1-R132 changes vary according to NPM1 and other mutations status in AML 241
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06 240
Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation 239
A Randomized, Phase 3, Trial of Interferon-α versus Hydroxyurea in Polycythemia Vera and Essential Thrombocythemia 238
Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: An EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine 237
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned 236
Unrelated cord blood transplantation for adult patients with acute myeloid leukemia : higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood-a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation 233
Economics and Outcome After Hematopoietic Stem Cell Transplantation : a Retrospective Cohort Study 232
A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis 232
Association of CFHR1 homozygous deletion with acute myelogenous leukemia in the European population 231
High-dose therapy and autologous stem cell transplantation in patients with poems syndrome : a retrospective study of the plasma cell disorder sub-committee of the chronic malignancy working party of the European society for blood & marrow transplantation 230
Concurrent diagnosis of acute myeloid leukemia and symptomatic covid-19 infection: A case report successfully treated with azacitidine-venetoclax combination 229
Non-myeloablative allografting for newly diagnosed multiple myeloma : the experience of the Gruppo Italiano Trapianti di Midollo. 228
A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients 227
High inter-follicular spatial co-localization of CD8+FOXP3+ with CD4+CD8+ cells predicts favorable outcome in follicular lymphoma 227
Immunotherapy of Acute Lymphoblastic Leukemia and Lymphoma With T Cell-Redirected Bispecific Antibodies 226
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML 226
Reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation in advanced mycosis fungoides and Sézary syndrome 225
T cell receptor (alpha, beta, gamma) gene rearrangements and expression in normal and leukemic large granular lymphocytes/natural killer cells 225
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis : a study on 2233 patients 225
Capture-based next-generation sequencing improves the identification of immunoglobulin/t-cell receptor clonal markers and gene mutations in adult acute lymphoblastic leukemia patients lacking molecular probes 224
Unrelated bone marrow transplantation with reduced-intensity regimen in high-risk patients for age or disease: a prospective GITMO study 223
Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome–positive B-precursor acute lymphoblastic leukemia 222
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea 222
JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis 221
Rate of primary refractory disease in B and T-cell non-Hodgkin's lymphoma: correlation with long-term survival 221
The HDAC inhibitor ITF2357 inhibits IL6-receptor expression and signaling in myeloma and leukemia cells 220
Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab : a 20-year retrospective follow-up study in patients with lymphoma 220
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B-Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial Including Rituximab in the Reduced Intensity Conditioning Regimen 220
Simple, rapid and accurate molecular diagnosis of acute promyelocytic leukemia by loop mediated amplification technology 219
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas : pre-transplant disease status and histotype heavily influence outcome 217
Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion : results from the National Registry of the Italian Drug Agency 217
Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia 215
The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy 214
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas : long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect 214
T cell receptor beta chain gene rearrangements in lymphoproliferative disorders of large granular lymphocytes/natural killer cells 213
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: A case-control study 212
Skip pattern approach toward the early access of innovative anticancer drugs 210
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (Gitmo) 209
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 208
Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term 207
Pleiotropic anti-myeloma activity of ITF2357 : inhibition of interleukin-6 receptor signaling and repression of miR-19a and miR-19b 206
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders : a phase 2 multicenter study 206
Totale 49.040
Salva come PNG Salva come JPEG
Categoria #
all - tutte 182.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 182.131
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021637 0 0 0 0 0 0 0 0 0 0 0 637
2021/20226.801 542 466 535 499 520 410 571 607 741 534 417 959
2022/20237.008 781 507 537 618 626 993 432 511 658 371 543 431
2023/202413.378 450 589 560 569 867 660 1.890 1.665 897 1.617 1.832 1.782
2024/202515.032 1.588 1.713 1.362 1.410 956 794 770 1.246 843 1.099 1.165 2.086
2025/202621.435 1.826 1.746 2.269 1.630 1.796 1.507 1.986 1.313 2.404 1.373 2.339 1.246
Totale 84.371